We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 12 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Sunswap is a solar and battery-powered transport refrigeration company that keeps food, medicine, and vaccines cold whilst on the road. The company argues that diesel-powered Transport Refrigeration Units (TRUs) are expensive to operate and highly polluting. It proclaims that replacing a diesel TRU with a Sunswap TRU could be the equivalent of removing 31 cars from the road. Sunswap asserts that the TRU market would have a market worth £13.4 billion by 2030. The company aims to be a contender in this segment and claims that electric TRU sales will follow the electric vehicle adoption curve with a 60% Year-on-Year growth. Sunswap has successfully tested its working prototype's capability to meet the temperature requirements of -22°C. It is collaborating with six major UK supermarkets on product development, with aims to secure sales with them in 2021. The company will use the investment to grow its team, build the next generation product, and secure sales by the end of 2021.
days to go: Expired investment: £535,000
Canny make and sell all natural flavoured milkshakes which are already being listed in stores across the UK and on Virgin trains. The 100% natural drinks provide 11 grams of protein per bottle and have less than 5% sugar, and will be launching a no refined sugar option this summer.
days to go: Expired investment: £172,780
The Halal Dining Club is a mobile app that has been designed to allow you to search your local area for catering establishments that offer Halal dishes. The Halal Dining Club allows you to search, book, review and get rewards all in one easy-to-use app.
days to go: Expired investment: £200,550
EeBriaTrade is a craft beer, cider and other drinks distributor, representing over 500 top breweries from across the UK and abroad. EeBria adopts a unique B2B marketplace model where, unlike other conventional distributors, the operation is entirely online. Since its launch in 2015, EeBria has witnessed strong growth in the UK with over 100% YoY growth in 2018, c.200% in 2017 and c.600% in 2016, and total sales of over £6.2m. It is raising funds to make its business global and planning to launch in at least eight new countries in 2019. EeBriaTrade is expected to see even faster growth in 2019 due to progress with Pub Chains, and because of new deals signed at the end of 2018 with Costcutter (1,700 stores) and NISA (2,000 stores).
days to go: Expired investment: £235,780
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph